Harvard University will lead a $100 million research effort to study chronic traumatic encephalopathy and a host of other devastating health problems in professional footballers...
Alzheimer's disease clinicians who have read the FDA's draft guidance on developing drug combinations consider it too vague to design trials with it...
In the AD field, most readers can count on one hand the companies that are widely known to have at least two drugs in sufficiently advanced stages to test combinations...
There were so many new data on neurodegenerative disease trials at the recent AAN meeting that organizers crammed some of them into a session of three-minute talks...
You could say the concept that endogenous proteins in the body can misfold, aggregate, and spread disease from cell to cell has created infectious enthusiasm for drug development...